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Background/aim: Irritable bowel syndrome (IBS) is a gastrointestinal condition characterized by chronic abdominal pain, discomfort,
bloating, and alteration of bowel habits in the absence of any organic cause. This trial investigated the presence of microscopic colitis
(MC) and associated factors related to MC in patients diagnosed with IBS.
Materials and methods: The study group (group I) consisted of 91 consecutive patients diagnosed with IBS based on the Rome III
Criteria for whom colonoscopic examination was requested. The control group (group II) had 41 patients diagnosed with IBS considered
as eligible for colonoscopic investigation due to specific conditions, and for whom colonoscopic examination was recommended for
screening purposes due to a familial history of colon cancer. Clinical data, endoscopic findings, and the effects of the therapy were
evaluated.
Results: In the diarrhea-predominant IBS group, nine patients (9.89%) were diagnosed with microscopic colitis, seven with lymphocytic
colitis (7.69%), and two with collagenous colitis (CC) (2.19%). None of the patients in group II were found to have MC (P = 0.007).
There were no diagnoses of MC in the constipation-predominant and mixed type IBS groups.
Conclusion: Clinicians should keep MC in mind for patients presenting with diarrhea-predominant IBS symptoms.
Key words: Irritable bowel syndrome, collagenous colitis, lymphocytic colitis

1. Introduction
Irritable bowel syndrome (IBS) is one of the most
common gastrointestinal conditions with a symptombased diagnosis. IBS is characterized by abdominal pain
and discomfort, bloating, and alteration of bowel habits in
the absence of any organic cause. The pathogenesis of IBS
remains uncertain, but recent studies have considered the
role of inflammation, alterations in fecal flora, bacterial
overgrowth, and a chronic low-grade inflammation of the
gastrointestinal mucosa (1). Diagnosis is symptom-based
because there are no biological, anatomical, physiological,
or colonoscopic markers for IBS and diagnostic criteria
should be fulfilled by the patients. Well-known algorithms
for diagnosis include the Manning criteria, the obsolete
Rome I and II criteria, the Kruis criteria, and the more
recent Rome III process (2). Furthermore, a variety of
dietary, pharmacological, and psychological treatments
have been studied in patients with IBS, but there is no
* Correspondence: fatih_ares@yahoo.com.tr

proven effective management for IBS. It also has significant
effects on quality of life with a high social cost. The total
cost of IBS in the United States has been estimated at
$21.7–$30 billion (3).
Several conditions with diarrhea may present as
diarrhea-predominant IBS, including parasitic infections
like giardiasis, fructose and bile acid malabsorption, small
intestinal bacterial overgrowth, inflammatory bowel
diseases, celiac disease, and microscopic colitis (MC).
MC may have a role among these conditions owing to its
similar symptoms and endoscopic appearance. Evaluation
of such patients may lead to a misdiagnosis of MC in
patients with IBS. Chronic diarrhea is the main symptom
both in patients with MC and diarrhea-predominant IBS,
but collagenous colitis and/or lymphocytic colitis might
be related to constipation and they are often accompanied
by abdominal pain (4,5). Furthermore, the mucosa
appears grossly normal or nearly normal at colonoscopy
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(6). In the presence of appropriate clinical symptoms, the
diagnosis of MC is established histologically, based on the
presence of intraepithelial lymphocytosis and a mixed
inflammatory infiltrate in the lamina propria (7). Many
cases of MC are self-limiting and silent, whereas others
are symptomatic for years in a relapsing or continuous
pattern. Symptoms of MC are often attributed to IBS,
so histologic investigations should be performed for the
above-mentioned IBS patients.
This trial was designed to investigate the presence and
incidence of MC and to reveal associated factors related to
MC, prospectively in patients diagnosed with IBS by Rome
III criteria.
2. Materials and methods
2.1. Selection of patients and the control group
After giving informed consent, 91 consecutive patients
were included in group I. These were patients presenting
to the Gastroenterology Department complaining of
abdominal pain, dyspepsia, distension, and changes in
defecation habit who were diagnosed with IBS by Rome
III Criteria and for whom a colonoscopic examination was
requested. None of the patients had a systemic illness or
were using any medications.
The control group for microscopic colitis (group
II) consisted of 41 patients considered as eligible for
colonoscopic investigation due to specific complaints
despite meeting Rome III criteria. In these patients,
colonoscopic examination was recommended for
screening purposes due to a familial history of colon
cancer. Informed consent was obtained from all patients
before beginning the colonoscopic examination.
2.2. Endoscopic examination
For all study subjects, a total colonoscopic examination was
performed using a Pentax EC 3840 endoscope following
appropriate colon cleansing, and 2 biopsies were obtained
from each of the cecum, ascending, transverse, descending,
and rectosigmoid colon segments for histopathological
investigation.
2.3. Pathological examination
Tissue samples obtained during colonoscopic investigation
were delivered to the pathology department in solutions
containing formaldehyde. After the preparation of
5-µm-thick paraffin blocks, the colon biopsies were dyed
with hematoxylin–eosin (H–E) and Gömöri trichrome
stains. All biopsy specimens were reviewed by an expert
gastrointestinal pathologist who was not aware of the
patients’ groups.
2.4. Criteria for microscopic colitis
Collagenous colitis (CC) and lymphocytic colitis (LC)
are 2 subtypes of MC. LC is defined by the flattening of
the surface epithelium, degenerative cuboidal changes,
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significant intraepithelial lymphocyte infiltration (more
than 20 lymphocytes for every 100 epithelial cells), and
mononuclear cell infiltration in the lamina propria. CC
was defined by subepithelial collagenous bands >10 µm in
thickness that were dyed with trichrome and H-E stains
(8).
2.5. Statistical analysis
Data from this trial were assessed using SPSS 17.0. A
Student’s t test and analysis of variance were used for
two-group and three-group comparisons respectively.
A chi-square test was used for dependence tests of the
categorical data. The level of significance was 0.05, with P
< 0.05 considered significant and P > 0.05 considered not
significant.
2.6. Ethical considerations
This study was approved by the Gazi University Local
Medical-Surgical Research and Drug Ethical Committee.
3. Results
The age and sex distribution of the patients are similar
between the two groups (P > 0.05, Table 1). Group I had 91
consecutive patients with IBS between 16 and 72 years of
age. The mean age was 42.71 ± 1.43, with 63 females and 28
males. Cases in the MC control group (group II) included
22 females and 19 males with an age range of 18–79 and a
mean age of 47.24 ± 2.33.
The patients with IBS were subdivided according to
Rome III criteria into three groups: 22 (24.17%) were
constipation-predominant, 55 (60.43%) were diarrheapredominant, and 14 (15.38%) were mixed diarrhea
and constipation. Symptom duration was found to be
significantly shorter in the diarrhea-predominant IBS
patients compared to the constipation-predominant and
mixed type patients (P = 0.0001, P = 0.005, and P < 0.05,
respectively)
In the diarrhea-predominant IBS group, nine patients
(9.89%) were histopathologically found to have MC; seven
were found to have LC (7.69%), and two had CC (2.19%).
None of the patients in group II were diagnosed with MC
(P = 0.007). No MC was diagnosed in the constipationpredominant and mixed type IBS group.
Table 1. Age and sex distribution of the patients with IBS and the
control group.
IBS
(group I)
n = 91

Control
(group II)
n = 41

Age (years)
mean ± sd

42.71 ± 1.43

47.24 ± 2.33

P > 0.05

Sex (M/F)

28/63

19/22

P > 0.05
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The distribution of the seven cases with LC revealed
two in the rectosigmoid, two in the descending colon and
rectosigmoid, one in the cecum and ascending colon, one
in the ascending, transverse, descending and rectosigmoid
colon, and one with whole colon involvement. The rectum
was spared in one case.
In the two patients with CC, descending colon
involvement was observed in one case, and rectosigmoid
colon involvement was observed in the other.
An evaluation of the nine patients with MC based on
demographic and clinical characteristics revealed that six
of the LC patients were female and one was male, with a
mean age of 44.6 ± 1.7; furthermore, one of the CC cases
was male while one was female, with a mean age of 57 ±
3.0. Their mean symptom duration was 44.6 ± 1.7 months.
All of these patients had been diagnosed with diarrheapredominant IBS. Their mean symptom duration was 36.6
± 4.1 months (Table 2).
4. Discussion
In this study we found that some patients presenting
with IBS symptoms can be diagnosed with MC. MC
shows a clinical similarity to IBS. LC and/or CC may be
related to constipation, although chronic diarrhea is the
main symptom in patients with both MC and diarrheapredominant IBS. In the literature, some studies reported
that many patients suffered not from episodes of watery
diarrhea but chronic constipation (5). In a trial assessing
symptomatic similarities between IBS and MC, diarrheapredominant IBS was reported in 28% of the MC cases
as per the Rome II criteria (8). The present trial shows
that all patients with MC were included in the diarrheapredominant IBS patient group (Figure).
In a previous study, it was reported that alternative
diagnoses should be investigated for IBS patients who

lack response to treatment and are followed up over
an extended period (9). In our study, in all cases where
MC was detected, the symptoms were found to last for a
minimum of 6 months to a maximum of 144 months. This
indicates that some of our patients were under monitoring
with a misdiagnosis of IBS for over 10 years. In female
diarrhea-predominant IBS patients with symptoms
persisting over an extended period, the potential presence
of MC should be kept in mind. There have been a few trials
in the literature that investigated the coexistence of MC
and IBS. In a recent trial, colon biopsy samples and clinical
data of 131 patients diagnosed with MC (84 LC and 47
CC) and 110 patients without an MC diagnosis from
whom a biopsy was obtained due to chronic diarrhea were
evaluated retrospectively (10). In that study, the presence
of symptoms required for IBS diagnosis by Rome II was
demonstrated in 56% of the histologically diagnosed MC
cases. Retrospectively, 43 of these patients (33%) were
found to have been monitored with a diagnosis of IBS
prior to biopsy. In the patient group consisting of 110
diarrhea patients without MC, a rate of 34% was detected
for IBS diagnostic criteria. Intergroup comparison showed
a statistically significant higher IBS diagnosis in the MC
group compared to the others.
A prospective trial by Chadwick et al. evaluated
colonoscopic biopsies of 77 patients diagnosed with IBS
as per the Rome I criteria and established a histologic
diagnosis of MC in 10% (11). In another trial, seven of 30
patients (23.3%) were diagnosed with IBS according to the
Manning criteria and one patient out of 20 in the control
group (5%) was found to have LC; the difference was
statistically significant. None of the patients were found
to have CC (12). A Turkish study reported the prevalence
of microscopic colitis in 30 patients diagnosed with IBS
by the Manning criteria to be 23% compared with 5% in

Table 2. Demographic and clinical characteristics of the patients diagnosed with MC.
Patient no.

Sex

Age

Symptom

Symptom duration (months)

Histology

5

F

41

Diarrhea

96

LC

10

F

44

Diarrhea

12

LC

24

M

50

Diarrhea

60

LC

25

F

60

Diarrhea

8

CC

29

F

40

Diarrhea

108

LC

34

M

54

Diarrhea

24

CC

52

F

52

Diarrhea

26

LC

69

M

41

Diarrhea

36

LC

80

M

44

Diarrhea

42

LC
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91 IBS patients

22 Constipation-dominant
IBS patients
(24.17%)

55 Diarrhea-dominant
IBS patients
(60.43%)

14 Diarrhea-dominant
IBS patients
(15.38%)

9 Microscopic colitis (9.8%)
patients
Sex (M/F) 2/7

2 Collagenous colitis (2.19%)
patients
Sex (M/F)1/6

7 Lymphocytic colitis (7.69%)
patients
Sex (M/F) 1/1

Figure. The number of IBS patients and distribution of MC patients in the
diarrhea-predominant IBS group.

a control group of 20 patients to be screened for colon
cancer or nonulcer dyspepsia (12).
In our study, investigation of biopsy samples obtained
by total colonoscopy from patients diagnosed with IBS
using the Rome III criteria revealed MC in nine patients
(9.89%) with seven found to have LC (7.69%) and two CC
(2.19%). None of the patients in the control group had
MC. In our study, all of the patients with MC were in the
diarrhea-predominant IBS group.
To rule out MC in patients diagnosed with diarrheapredominant IBS, a histopathological assessment of
colonoscopic biopsies is required. Some trials recommend
only rectal biopsy (13,14) while some report that rectal
biopsy alone is insufficient due to the variable anatomic
distribution of MC cases (15,16) and the higher level
of proximal colon involvement compared to distal
involvement (17). In our series, assessment of the
seven cases with LC by colon segment revealed cecum
involvement in one case, a combination of cecum,
transverse colon, descending colon, and rectosigmoid
colon involvement in two cases, a combination of
descending colon and rectosigmoid colon involvement
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in two cases, and rectosigmoid colon involvement in two
cases. In the two patients with CC, descending colon and
rectosigmoid colon involvement was observed in one,
and rectosigmoid colon involvement was observed in the
other. Based on the literature data and the results from our
trial, we think that right colon biopsies are necessary for
diagnosis in diarrhea-predominant IBS patients with a
negative rectal biopsy in the event of suspicion of MC.
In conclusion, among patients diagnosed with IBS,
those with symptoms persisting for a long period, those
with diarrhea-predominant IBS and a short duration of
symptoms, or those with a poor response to treatment, the
actual diagnosis may be MC with symptoms overlapping
with IBS. As is also indicated in the literature and by our
trial, we conclude that histological investigations should
be performed in the above-mentioned IBS patients by
obtaining biopsies from the whole colon, as biopsies
obtained only from the rectosigmoid are not adequate
for the diagnosis of MC. This is important to avoid
unnecessary, excessive, and long-term drug use by patients
as well as to prevent losses in workforce efficiency and to
reduce morbidity.
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